Biologicals, platelet apoptosis and human diseases: An outlook

Thushara, R. M. and Hemshekhar, M. and Basappa and Kemparaju, K. and Rangappa, K. S. and Girish, K. S. (2015) Biologicals, platelet apoptosis and human diseases: An outlook. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 93 (3). pp. 149-158. ISSN 1879-0461

Full text not available from this repository. (Request a copy)
Official URL:


Platelets, once considered mediators of hemostasis and thrombosis, are now known to be involved in wound healing, inflammation, cardiovascular diseases, diabetes, arthritis, and cancer. Recent reports attest that platelets possess the cellular machinery to undergo apoptosis and that platelet apoptosis can be triggered by myriad stimuli including chemical and physical agonists, and pathophysiological conditions. Augmented rate of platelet apoptosis leads to thrombocytopenia, bleeding disorders and microparticle generation. Despite knowing the significant role of platelets in health and disease, and that any alterations in platelet functions can wreak havoc to.the health, the offshoot reactions of therapeutic drugs on platelets and the far-reaching consequences are often neglected. The present review focuses on the impact of platelet apoptosis and the role of platelet-derived microparticles on different pathophysiological conditions. It also touches upon the effects of biologicals on platelets, and discusses the need to overcome the adverse effects of pro-apoptotic drugs through auxiliary therapy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Item Type: Article
Subjects: C Chemical Science > Biochemistry
C Chemical Science > Chemistry
Divisions: Department of > Biochemistry
Department of > Chemistry
Depositing User: Users 19 not found.
Date Deposited: 13 Jun 2019 10:44
Last Modified: 13 Jun 2019 10:44

Actions (login required)

View Item View Item